Cargando…

Veterinary Medicine Needs New Green Antimicrobial Drugs

Given that: (1) the worldwide consumption of antimicrobial drugs (AMDs) used in food-producing animals will increase over the coming decades; (2) the prudent use of AMDs will not suffice to stem the rise in human antimicrobial resistance (AMR) of animal origin; (3) alternatives to AMD use are not av...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toutain, Pierre-Louis, Ferran, Aude A., Bousquet-Melou, Alain, Pelligand, Ludovic, Lees, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971058/ https://www.ncbi.nlm.nih.gov/pubmed/27536285 http://dx.doi.org/10.3389/fmicb.2016.01196

Ejemplares similares

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
por: Toutain, Pierre-Louis, et al.
Publicado: (2017)

Biased computation of probability of target attainment for antimicrobial drugs
por: Toutain, Pierre‐Louis, et al.
Publicado: (2023)

Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms
por: Ferran, Aude A., et al.
Publicado: (2016)

In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations
por: Lallemand, Elodie A., et al.
Publicado: (2016)

Pharmacokinetic–pharmacodynamic cutoff values for benzylpenicillin in horses to support the establishment of clinical breakpoints for benzylpenicillin antimicrobial susceptibility testing in horses
por: Lallemand, Elodie A., et al.
Publicado: (2023)

Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus
por: Broussou, Diane C., et al.
Publicado: (2019)

VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle
por: Toutain, Pierre-Louis, et al.
Publicado: (2019)

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
por: Concordet, Didier, et al.
Publicado: (2019)

Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model
por: Broussou, Diane C., et al.
Publicado: (2018)

Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and in silico Dose Fractionation for Calf Respiratory Pathogens
por: Pelligand, Ludovic, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, Didier, et al.
Publicado: (2019)

Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo Efficacies
por: Lhermie, Guillaume, et al.
Publicado: (2015)

Comparison of veterinary drugs and veterinary homeopathy: part 1
por: Lees, P., et al.
Publicado: (2017)

Comparison of veterinary drugs and veterinary homeopathy: part 2
por: Lees, P., et al.
Publicado: (2017)

Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice
por: Vasseur, Maleck V., et al.
Publicado: (2017)

Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
por: Lallemand, Elodie Anne, et al.
Publicado: (2021)

Population Pharmacokinetics of Intravenous Amoxicillin Combined With Clavulanic Acid in Healthy and Critically Ill Dogs
por: Vegas Cómitre, Maria D., et al.
Publicado: (2021)

Towards a Better and Harmonized Education in Antimicrobial Stewardship in European Veterinary Curricula
por: Espinosa-Gongora, Carmen, et al.
Publicado: (2021)

Implementing Precision Antimicrobial Therapy for the Treatment of Bovine Respiratory Disease: Current Limitations and Perspectives
por: Lhermie, Guillaume, et al.
Publicado: (2017)

The Decline and Fall of Materia Medica and the Rise of Pharmacology and Therapeutics in Veterinary Medicine
por: Lees, Peter, et al.
Publicado: (2022)

Prediction of Minocycline Activity in the Gut From a Pig Preclinical Model Using a Pharmacokinetic -Pharmacodynamic Approach
por: Vallé, Quentin, et al.
Publicado: (2021)

A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients
por: Bousquet-Mélou, Alain, et al.
Publicado: (2021)

Authors’ Reply to Krebs-Brown et al. Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, D., et al.
Publicado: (2019)

Quantitative Pharmacodynamic Characterization of Resistance versus Heteroresistance of Colistin in E. coli Using a Semimechanistic Modeling of Killing Curves
por: Mead, Andrew, et al.
Publicado: (2022)

Targeted dosing for susceptible heteroresistant subpopulations may improve rational dosage regimen prediction for colistin in broiler chickens
por: Mead, Andrew, et al.
Publicado: (2023)

Impact of Timing and Dosage of a Fluoroquinolone Treatment on the Microbiological, Pathological, and Clinical Outcomes of Calves Challenged with Mannheimia haemolytica
por: Lhermie, Guillaume, et al.
Publicado: (2016)

Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
por: Lees, Peter, et al.
Publicado: (2022)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
por: Cagnardi, Petra, et al.
Publicado: (2018)

Time-Kill Analysis of Canine Skin Pathogens: A Comparison of Pradofloxacin and Marbofloxacin
por: Azzariti, Stefano, et al.
Publicado: (2023)

Levers to Improve Antibiotic Treatment of Lambs via Drinking Water in Sheep Fattening Houses: The Example of the Sulfadimethoxine/Trimethoprim Combination
por: Ferran, Aude A., et al.
Publicado: (2020)

Destruction of Staphylococcus aureus biofilms by combining an antibiotic with subtilisin A or calcium gluconate
por: Liu, JingJing, et al.
Publicado: (2021)

Comment on “In Vitro Effects of Bisphenol A β-D-Glucuronide (BPA-G) on Adipogenesis in Human and Murine Preadipocytes”
por: Gayrard, Véronique, et al.
Publicado: (2015)

Repeated Exposure of Escherichia coli to High Ciprofloxacin Concentrations Selects gyrB Mutants That Show Fluoroquinolone-Specific Hyperpersistence
por: Perault, Aurore, et al.
Publicado: (2022)

High Bioavailability of Bisphenol A from Sublingual Exposure
por: Gayrard, Véronique, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dipsmjta503stsepg483lrjfj9